Corrigendum to “Obinutuzumab induction and maintenance in patients with Waldenström macroglobulinaemia: an open-label, single-arm phase 2 study” EClinicalMedicine. 2025 Jul 25:86:103383
Corrigendum to “Obinutuzumab induction and maintenance in patients with Waldenström macroglobulinaemia: an open-label, single-arm phase 2 study” EClinicalMedicine. 2025 Jul 25:86:103383
Dominik Dytfeld, E. Lech-Marańda, Agnieszka Szeremet, Bartosz Małecki et al.
Journal
EClinicalMedicine
Topics
Chronic Lymphocytic Leukemia Research
article
Corrigendum to “Obinutuzumab induction and maintenance in patients with Waldenström macroglobulinaemia: an open-label, single-arm phase 2 study” EClinicalMedicine. 2025 Jul 25:86:103383
Dominik Dytfeld, E. Lech-Marańda, Agnieszka Szeremet, Bartosz Małecki, Marta Morawska, Elżbieta Kalicińska, Krzysztof Giannopoulos, Tomasz Wróbel, Anna Łojko-Dankowska, Michał Taszner, Agnieszka Druzd-Sitek, Jan Maciej Zaucha, Krzysztof Jamroziak
article en
Abstract
No abstract available for this paper.
Publication Tag
EClinicalMedicineVol. 94
Institutions
Poznan University of Medical Sciences (PL), Medical University of Lublin (PL), Medical University of Warsaw (PL), Wroclaw Medical University (PL), Instytut Hematologii i Transfuzjologi (PL), The Maria Sklodowska-Curie National Research Institute of Oncology (PL), Gdańsk Medical University (PL)